FDA Approved Peptide Drugs in the First Half of 2023
The FDA’s Center for Drug Evaluation and Research (CDER) regulatory approval of a total of 26 NME (New Molecular Entity) drugs in the first half of 2023. It is worth noting that the 26 drugs approved include 4 peptide drugs, accounting for 15% of the total. In the past 2022, the FDA has approved only…
Read More “FDA Approved Peptide Drugs in the First Half of 2023” »